20892 ⎘
Medicinal preparations containing peptides Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Peptides based on the transmembrane domain of a toll-like receptor (TLR) for treatment of TLR-mediated diseases
#302CCN3 and CCN3 peptides and analogs thereof for therapeutic uses
#303Bioactive peptide
#304Growth hormone secretatogue receptor antagonists and uses thereof
#305Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth
#306Compositions and methods for the prevention of cancer in high risk patients
#307COMPOSITIONS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN CFTR AND CAL
#30899mTc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical
#309Treatment of influenza virus infection
#310Composition for improving brain function and method for improving brain function
#311Treating liver diseases
#312RumC peptides with antimicrobial activity
#313Anticonvulsant combination therapy
#314Anti-HIV peptides and methods of use thereof
#315THERAPEUTIC AGENT FOR PULMONARY SMALL CELL CARCINOMA
#316Compounds and methods for purifying peptides produced by solid phase peptide synthesis
#317Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
#318BIOAVAILABLE COMBINATIONS FOR HCV TREATMENT
#319Peptide aptamers that bind to the rep proteins of ssDNA viruses
#320PAR-1 antagonists for use in the treatment or prevention of influenza virus type A infections
#321USE OF PROTEIN KINASE C DELTA (PKCD) INHIBITORS TO TREAT DIABETES, OBESITY, AND HEPATIC STEATOSIS
#322Vaccines and compositions against
#323Compounds and methods for treating bone disorders and controlling weight
#324Methods for Treating Immune Mediated Neurological Diseases
#325Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease
#326Vaccine comprising AMB A 1 peptides for use in the treatment of ragweed allergy
#327PROPHYLACTIC OR THERAPEUTIC AGENT FOR RETINAL DISEASE AND METHOD FOR PROPHYLAXIS OR THERAPY OF RETINAL DISEASE USING JNK (C-JUN AMINO-TERMINAL KINASE) - INHIBITORY PEPTIDE, AND USE OF THE PEPTIDE
#328Methods for preventing and treating angioedema
#329HUMAN EPO MIMETIC HINGE CORE MIMETIBODIES, COMPOSITIONS, METHODS AND USES FOR PREVENTING OR TREATING GLUCOSE INTOLERANCE RELATED CONDITIONS OR RENAL DISEASE ASSOCIATED ANEMIA
#330Compositions and methods for inhibiting the interaction between CFTR and CAL
#331Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
#332Albumin fusion proteins
#333Inflammation inhibiting compounds
#334Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention
#335Methods for the treatment of cancer
#336Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp
#337Inhibiting tumor cell invasion, metastasis and angiogenesis
#338METHODS FOR INCREASING EFFICACY OF RADIOIMMUNOTHERAPY OF MELANOMA
#339Compounds
#340MATERIALS AND METHODS FOR TREATMENT OF INFLAMMATION
#341Peptides, derivatives and analogs thereof, and methods of using same
#342METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF COMPOUNDS
#343Radiolabeled annexins
#344Compositions and methods for the treatment of neurologic and psychiatric conditions
#345Dermcidin-derived peptides for lung cancer diagnostics
#346Methods and compositions for inhibition of BCL6 repression
#347Compositions and methods for treating diseases
#348Blood sugar-modulating polypeptides
#349Wound healing peptides and methods of use thereof
#350METHOD OF TREATING PERIPHERAL ARTERIAL DISEASE
#351Peptide composition and a method of promoting cartilage formation
#352Methods and compositions for ameliorating the undesirable effects of chemotherapy
#353TREATMENT OF DISEASES AND CONDITIONS MEDIATED BY EICOSANOIDS
#354Factor H for the treatment of chronic nephropathies and production thereof
#355COMBINATION THERAPY FOR TREATING HEPATITIS VIRAL INFECTION
#356Compositions comprising E-selectin antagonists and uses therefor
#357Albumin fusion proteins
#358Treatment of immunocompromised conditions
#359Therapy for hyperexcitability disorders
#360Method of reduction of wrinkles on skin or acceleration of wound healing by applying peptides related to basic fibroblast growth factor (bFGF)
#361Use of melanocortins to treat insulin sensitivity
#362METHOD AND COMPOSITION FOR REDUCING REPERFUSION INJURY
#363High-potency botulinum toxin formulations
#364Uses for amino acid anticonvulsants
#365PEPTIDE COMPOUNDS FOR TREATING REFRACTORY STATUS EPILEPTICUS
#366Immunity to folate receptors
#367Modifications of cupredoxin derived peptides and methods of use thereof
#368Method for treating atypical facial pain
#369COMBINATION THERAPY FOR PAIN IN PAINFUL DIABETIC NEUROPATHY
#370Anticonvulsant combination therapy
#371IDO inhibitors and methods of use
#372FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE
#373Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention
#374Acyl pseudodipeptides which carry a functionalized auxiliary arm
#375Antimicrobial peptide, compositions, and methods of use
#376NOVEL PEPTIDES
#377Peptide-based stat inhibitor
#378COMBINATIONS USEFUL FOR THE TREATMENT OF NEURONAL DISORDERS
#379Cell-permeant peptide-based inhibitor of kinases
#380Influenza inhibiting compositions and methods
#381BLOOD SUGAR-MODULATING POLYPEPTIDES
#382Process for the Manufacture of Eptifibatide
#383Regulation of TLR Signaling by Complement
#384Peptides, derivatives and analogs thereof, and methods of using same
#385Peptide-presenting surfaces for long-term culture of pluripotent cells
#386METHODS AND COMPOSITIONS FOR PRESERVING THE VIABILITY OF PHOTORECEPTOR CELLS
#387Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
#388CXCR4 antagonists for wound healing and re-epithelialization
#389Tc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical
#390Synergistic Pharmaceutical Composition
#391HUMAN EPO MIMETIC HINGE CORE MIMETIBODIES, COMPOSITIONS, METHODS AND USES FOR PREVENTING OR TREATING GLUCOSE INTOLERANCE RELATED CONDITIONS ON RENAL DISEASE ASSOCIATED ANEMIA
#392Composition Designed For The Treatment Of Multiple Sclerosis
#393COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#394Glycopeptide antibiotic derivative
#395USE OF CALMODULIN KINASE II INHIBITORS TO TREAT OR PREVENT HEART MUSCLE INFLAMMATION
#396Influenza virus inhibiting peptides
#397NASAL DELIVERY OF THERAPEUTIC AGENTS USING TIGHT JUNCTION AGONISTS
#398METHOD FOR IDENTIFYING CRMP MODULATORS
#399Methods and compositions for treating cancer
#400Methods for monitoring IL-18
#401Peptides that selectively home to heart vasculature and related conjugates and methods
#402Inhibiting tumor cell invasion, metastasis and angiogenesis
#403Treating liver diseases
#404Salicylanilides enhance oral delivery of therapeutic peptides
#405METHODS OF INHIBITING ANGIOGENESIS WITH FRAGMENTS AND HOMOLOGS OF TROPONIN SUBUNIT I
#406Methods of screening for compounds that inhibit binding between amyloid-β(Aβ) and FC-γ receptor IIB (FcγRIIb)
#407Factor H for the Treatment of Chronic Nephropathies and Production thereof
#408Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
#409METHODS FOR TREATING IMMUNE MEDIATED NEUROLOGICAL DISEASES
#410Albumin Fusion Proteins
#411Albumin Fusion Proteins
#412Methods for construction and screening of libraries of chemokine variants
#413Peptide composition and a method of promoting cartilage formation
#414Agonist Peptides of Basic Fibroblast Growth Factor (bFGF) and the Method of Reduction of Wrinkles on Skin, Darkening of Hair and Acceleration of Wound Healing
#415Compositions and methods for treating diseases
#416NOD1 as an Anti-Tumor Agent
#417Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
#418proteins, nucleic acids, and methods of their use
#419Peptides, derivatives and analogs thereof, and methods of using same
#420Peptide aptamers that bind to the rep proteins of ssDNA viruses
#421Treatment of trauma-hemorrhage with short oligopeptides
#422Metallopeptide gamma-Melanocyte Stimulating Hormone Compounds
#423Albumin fusion proteins
#424Methods for Treating Alzheimer's Disease
#425Methods for Treating Parkinson's Disease
#426Plant Extracts for the Treatment of Incresed Bone Resorption
#427Orally active peptides that prevent cell damage and death
#428NY-ESO-1 peptides which bind to class II molecules and uses thereof
#429Methods for Treating Amyotrophic Lateral Sclerosis
#430Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
#431Albumin Fusion Proteins
#432Albumin fusion proteins comprising insulin polypeptides
#433Albumin Fusion Proteins
#434G-CSF-albumin fusion proteins
#435Diagnosis and Treatment of Myeloid and Lymphoid Cell Cancers
#436Novel Melanocortin Receptor Templates, Peptides, and Use Thereof
#437Albumin fusion proteins
#438Novel Melanocortin Receptor Templates, Peptides, and Use Thereof
#439PROTEASE INHIBITORS
#440Sustained-Release Composition, Process for Producing the Same and Use of the Same
#441Cardiovascular compositions and methods using combinations of anti-platelet agents
#442Glycopeptide antibiotic monomer derivatives
#443Serotonin antagonist compositions and methods for the local inhibition of pain and inflammation
#444Diagnosis and treatment for immunoglobulin E (IgE) implicated disorders
#445Peptides selectively lethal to malignant and transformed mammalian cells
#446Methods And Compositions For The Treatment Of Gastrointestinal disorders
#447Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and related methods of use
#448Albumin fusion proteins
#449Dual function polymer micelles
#450Albumin fusion proteins
#451Peptides selectively lethal to malignant and transformed mammalian cells
#452Medicaments and methods combining a HCV protease inhibitor and an AKR competitor
#453Compositions and methods for treating diseases
#454Novel PEGylation agent
#455IDO inhibitors and methods of use
#456Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux
#457Uses for amino acid anticonvulsants
#458Composition containing dipeptide of histidine and alanine for reducing uric acid and method for reducing uric acid using the dipeptide
#459Methods for the treatment of cancer
#460Peptides, derivatives and analogs thereof, and methods of using same
#461Methods and compositions for treating cancer
#462Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
#463Combination therapy for pain in painful diabetic neuropathy
#464Methods and compositions for preserving the viability of photoreceptor cells
#465Treating diabetes with glucagon-like peptide-1 secretagogues
#466Method for treatment of vitiligo
#467Liver/plasma concentration ratio for dosing hepatitis C virus protease inhibitor
#468Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
#469Asymmetric dosing methods
#470Novel treatment for pathological aggression
#471Crystalline (2E,4S)-4-[(N-{[(2R)-1-isopropylpiperidin-2-yI]-carbonyl}-3-methyl-L-valyl)(methyl)amino]-2,5-dimethylhex-2-enoic acid and its pharmaceutical uses
#472Method for modulating activity of HCV protease through use of a novel HCV protease inhibitor to reduce duration of treatment period
#473Influenza virus inhibiting peptides
#474Methods of treating hepatitis C virus
#475Methods of treating hepatitis C virus
#476Methods for treating hepatitis C
#477Medicaments and methods combining a HCV protease inhibitor and an AKR competitor
#478Albumin fusion proteins
#479Controlled-release formulation
#480Methods for inhibition of angiogenesis
#481Melanocortin receptor templates, peptides and use thereof
#482Retroviral protease inhibitor combinations
#483Enternal administration of arginine and glutamine for abnormal vascular proliferation
#484Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof
#485Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1
#486Roflumilast and integrin inhibitor combination and treatement method
#487NOD1 as an anti-tumor agent
#488Albumin fusion proteins
#489High-potency botulinum toxin formulations
#490Restoring vascular function
#491Novel conjugates of polysaccharides and uses thereof
#492Peptides that selectively home to heart vasculature and related conjugates and methods
#493Tubulin isotype screening in cancer therapy using hemiasterlin analogs
#494Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux
#495Method for treating pain in trigeminal neuralgia
#496Dalfopristine/quinupristine combinations with cefpirome
#497Combined use of carnosinase inhibitor with l-carnosines and composition
#498Novel use of peptide compounds for treating pain in painful diabetic neuropathy
#499Methods and compositions for ameliorating the undesirable effects of chemotherapy
#500Apoptosis-mimicking natural vesicles and use thereof in medical treatment
#501Metallopeptide compounds
#502Method for treating dyskinesia
#503Anticancer peptide compositions
#504Method for identifying immunoreactive peptides
#505Method for treating central neuropathic pain
#506Methods for monitoring IL-18
#507Novel acyl-dipeptide-like compounds bearing an accessory functional side chain spacer, a method for preparing the same and pharmaceutical compositions containing such products
#508Compositions and methods for treating diseases
#509Albumin fusion proteins comprising GLP-1 polypeptides
#510Combinations useful for the treatment of neuronal disorders
#511Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases
#512Protease inhibitors
#513Method of inhibiting factor B-mediated complement activation
#514Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
#515Anti-inflammatory/anti-microbial peptides for use in dialysis
#516Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
#517Stabilized ocular solutions
#518Medicament against thrombotic diseases
#519Water-soluble SHPs as novel alkylating agents
#520Systems and methods for treatment of hearing using dihexa